Document:

Severance and Change of Control Agreement

 Exhibit 10.2 

SEVERANCE AND CHANGE OF CONTROL AGREEMENT 

THIS SEVERANCE AND CHANGE OF CONTROL AGREEMENT (this “Agreement”) is entered into by and between Orthovita, Inc., a
Pennsylvania corporation having its principal offices in Malvern, PA (the “Company”), and Maarten Persenaire, M.D. (the “Executive”) effective August 4, 2010 (the “Effective Date”). 

WHEREAS, the Company desires to provide Executive: (i) severance termination benefits (prior to a change in control),
(ii) change of control termination benefits (on or after a change in control), and (iii) certain death and disability benefits on the terms and conditions, and for the consideration, hereinafter set forth, and Executive desires to be
employed by Company on such terms and conditions and for such consideration; 
 WHEREAS, the benefits provided to
Executive under this Agreement are described in the following Sections: (i) Section 6 outlines the severance termination benefits (prior to a change of control), (ii) Sections 6 and 11 outline the double-trigger change in control
termination benefits (on or after a change in control), and (iii) Sections 8 and 9 outline the death and disability benefits; and 

WHEREAS, in addition to providing the benefits outlined in Sections 6, 8, 9 and 11 (as described above), this Agreement imposes
duties and obligations and other requirements as follows: (i) Section 1 imposes a duty of loyalty on Executive, (ii) Section 6, 7 and 10 outline the triggers to terminate employment, (iii) Section 6 requires Executive
to sign a release to receive benefits (other than death or disability benefits), (iv) Section 13 imposes restrictive covenants on Executive, and (v) Section 15 includes a mandatory arbitration provision, as well as other
miscellaneous provisions. 
 NOW, THEREFORE, in consideration of the premises and of the mutual covenants and agreements hereinafter set forth,
the Company and the Executive hereby agree as follows: 
 1. Employment. 

(a) Duties. 

(i) The Executive shall serve as the Chief Medical Officer of the Company with duties, responsibilities and authority
commensurate therewith and shall report to the Chief Executive Officer. The Executive shall perform all duties and accept all responsibilities incident to such position as may be reasonably assigned to him/her by the Chief Executive Officer.

 (ii) The Executive represents to the Company that he/she is not subject to or a party to any employment
agreement, non-competition covenant, understanding or restriction which would be breached by or prohibit the Executive from executing this Agreement and performing fully his/her duties and responsibilities hereunder. 

 (b) Term. This Agreement shall begin on the Effective Date and shall terminate
automatically on the earlier of (i) Executive’s termination of employment with Company or (ii) the first anniversary of a Change of Control (as defined below) or (iii) the date on which Executive, while remaining employed by the
Company, ceases to serve as an executive of the Company (the “Term”). 
 (c) Best Efforts. During the Term, the
Executive shall devote his/her best efforts and full time and attention to promote the business and affairs of the Company and its affiliated entities, and shall be engaged in other business activities only to the extent that such activities do not
materially interfere or conflict with the Executive’s obligations to the Company hereunder, including, without limitation, obligations pursuant to Section 13 below. The foregoing also shall not be construed as preventing the Executive from
(1) serving on civic, educational, philanthropic or charitable boards or committees, or, with the prior written consent of the Board of Directors of the Company (the “Board”), in its sole discretion, on corporate boards, and
(2) managing personal investments, so long as such activities are permitted under the Company’s Code of Conduct and employment policies. Notwithstanding any provision of this Section 1 of the Agreement to the contrary, in no event
shall the Executive invest in any business competitive with the Company or that would otherwise violate the provisions of Section 13 below (other than as a shareholder of less than 1% of a publicly traded company). 

2. Base Salary and Bonus. 

(a) During the Term, for all of the services rendered by the Executive hereunder, the Company shall pay Executive a base salary
(“Base Salary”), at the initial annual rate of $277,600, payable in installments at such times as the Company customarily pays its other employees. The Executive’s Base Salary shall be reviewed periodically by the Board (or a
committee of the Board) pursuant to the Board’s normal performance review policies for officers at Executive’s level. 

(b) In addition, during the Term, the Executive shall be eligible to receive an annual bonus based on the attainment of individual and
corporate performance goals and targets, as determined by the Board (or a Board committee), in its sole discretion, as of the beginning of each fiscal year. The target bonus for the Executive for any calendar year during the Term shall be as
established by the Board or Board committee, provided, however that the Executive’s target bonus opportunity shall be based on not less than 50% of the Executive’s Base Salary in effect for such calendar year. Promptly after receipt of the
financial or other information on which the performance goals are based after the end of the fiscal year, the Board (or Board committee) shall review actual performance against the applicable performance goals and targets and shall notify the
Executive of the amount of the Executive’s bonus, if any. The Executive’s bonus shall be paid to him/her after the end of the fiscal year to which it relates, at the same time and under the same terms and conditions as other executives of
the Company; provided that in no event shall the Executive’s bonus be paid later than March 15 of the calendar year following the fiscal year for which it was earned. 

 

 2 

 3. Retirement and Welfare Benefits. The Executive shall be eligible to participate in
the Company’s health, life insurance, long and short-term disability, dental, retirement, savings and medical programs, directors and officers liability insurance and other benefit plans or programs generally made available to other officers of
the Company at Executive’s level, if any, pursuant to their respective terms and conditions. In addition, the Executive shall be eligible to participate in any long-term equity incentive programs (including the Company’s 2007 Omnibus
Equity Compensation Plan and any successor plan) established by the Company for its executives generally at levels determined by the Board (or a Board committee) in its sole discretion, commensurate with the Executive’s position as Chief
Medical Officer. Nothing in this Agreement shall preclude the Company or any affiliate of the Company from terminating or amending any employee benefit plan or program from time to time after the Effective Date. 

4. Vacation. The Executive shall be entitled to vacation, holiday and sick leave at levels commensurate with those provided to
other senior executive officers of the Company, in accordance with the Company’s vacation, holiday and other pay for time not worked policies. 

5. Expenses. The Company shall reimburse the Executive for all necessary and reasonable travel and other business expenses
incurred by the Executive in the performance of his/her duties hereunder in accordance with such reasonable accounting procedures as the Company may adopt generally from time to time for executives. 

6. Termination Without Cause; Resignation for Good Reason following a Change of Control. The provisions of this Section 6
shall apply if either (i) the Executive’s employment is terminated by the Company without Cause (as defined in Section 12 below) or (ii) the Executive resigns under this Section 6 for Good Reason within 12 months following a
Change of Control. The Executive shall give the Company not less than 30 days’ prior written notice of such resignation. 

(a) The Company may terminate the Executive’s employment with the Company at any time without Cause upon not less than 30 days’
prior written notice to the Executive; provided that, in the event that such notice is given, the Executive shall be under no obligation to render any additional services to the Company and shall be allowed to seek other employment. In addition, on
the date of the Executive’s termination of employment for any reason, the Executive agrees to resign all positions, including as an officer and, if applicable, as a director or member of the board of directors, of the Company and its parents,
subsidiaries and affiliates. 
 (b) Unless the Executive complies with the provisions of Section 6(c) below, upon
termination without Cause at any time or resignation for Good Reason following a Change of Control under Section 6(a) above, the Executive shall be entitled to receive only the amount due to the Executive under the Company’s then current
severance pay plan for employees, if any, but only to the extent not conditioned on the execution of a release by the Executive. No other payments or benefits shall be due under this Agreement to the Executive, but the Executive shall be entitled to
any benefits accrued and due in accordance with the terms of any applicable benefit plans and programs of the Company. 
  

 3 

 (c) Notwithstanding the provisions of Section 6(b), upon termination without Cause at
any time or resignation for Good Reason following a Change of Control under Section 6(a) above, as applicable, if the Executive executes and does not revoke a written release, in a form acceptable to the Company, in its sole discretion,
of any and all claims against the Company and all related parties with respect to all matters arising out of the Executive’s employment by the Company, or the termination thereof (other than claims for any entitlements under the terms of this
Agreement or under any plans or programs of the Company under which the Executive has accrued and is due a benefit) (the “Release”), the Executive shall be entitled to receive, in lieu of the payment described in Section 6(b) and any
other payments due under any severance plan or program for employees or executives, the following: 
 (i) An
amount equal to 18 months of the Executive’s annual Base Salary (at the rate in effect immediately before the Executive’s termination), payable in normal installments in accordance with the Company’s payroll practices; provided,
however, that if Executive’s termination without Cause occurs prior to a Change of Control or after 12 months following a Change of Control, the amount payable under this Section 6(c)(i) shall equal 12 months. Payments shall
commence within 60 days after the effective date on which the Executive’s employment terminates, on the first payroll date following expiration of the maximum revocation period applicable to the Release, except as provided in
Section 6(c)(vi) below. 
 (ii) A pro rata bonus for the year in which the Executive’s termination of
employment occurs to the extent that such amount would have been earned in accordance with the terms of the Company’s annual incentive program only with respect to the calendar year in which the Executive’s termination of employment
occurs, without regard to a requirement, if any, that the Executive be employed by the Company on the date of payment. The pro-rata bonus shall be payable at the date on which other bonuses are paid for the year after the end of the fiscal year to
which it relates; provided that in no event shall the Executive’s pro rata bonus be paid later than March 15 of the calendar year following the fiscal year for which it was earned, except as provided in Section 6(c)(vi) below.

 (iii) A monthly payment, on the first payroll date of each month, equal to the monthly Executive’s COBRA
health care continuation coverage premium under Section 4980B of the Code under the Company’s medical plan, for the period following the Executive’s termination equal in duration to the severance period described in
Section 6(c)(i) above or until the date on which the Executive is eligible for coverage under a plan maintained by a new employer or under a plan maintained by his/her spouse’s employer, whichever is sooner, for himself/herself and, where
applicable, his/her spouse and dependents. 
 (iv) Notwithstanding any provision to the contrary in any
applicable plan, program or agreement, all outstanding stock options, restricted stock, restricted stock units and other equity rights held by the Executive as of the date of the Executive’s resignation for Good Reason within 12 months
following a Change of Control or termination without Cause within 12 months following a Change of Control will become fully vested and exercisable as of the date on which the Executive’s resignation for Good Reason or termination without Cause
following a Change of Control occurs. This subsection 6(c)(iv) shall not apply upon Non-Renewal. 
  

 4 

 (v) Any other amounts earned, accrued and owing but not yet paid under
Section 2 above (Base Salary and Bonus) and any benefits accrued and due under any applicable benefit plans and programs of the Company. 

(vi) If the Executive is determined to be a Specified Executive (as defined in Section 12(e) below), any amounts
payable to him/her upon separation from service that are deferred compensation under Section 409A of the Code shall be postponed and shall be paid in a lump sum after the first to occur of (i) the date that is six months following the
Executive’s separation from service or (ii) the Executive’s death. The lump sum payment of such postponed amounts shall be made within five days following the end of the six-month period or within 60 days following the
Executive’s death, as applicable. The Section 409A postponement period shall not apply to: 
 (1)
separation pay that is exempt from Section 409A under the separation pay exception, which exempts an amount up to two times the lesser of (a) the Executive’s annualized compensation for the year prior to the year of separation, or
(b) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code and which is paid no later than the last day of the Executive’s second taxable year following the taxable year in
which his/her separation from service occurs; and 
 (2) any amount exempt from Section 409A under the short
term deferral exception. 
 7. Voluntary Termination. The Executive may voluntarily terminate his/her employment for any
reason upon 30 days’ prior written notice. In such event, after the effective date of such termination, no payments shall be due under this Agreement, except that the Executive shall be entitled to any amounts earned, accrued and owing but not
yet paid under Section 2 above and any benefits accrued and due under any applicable benefit plans and programs of the Company. 

8. Disability. If the Executive incurs a Disability (as defined in Section 12 below) during the Term, the Executive’s
employment shall terminate on the date of Disability. If the Executive’s employment terminates on account of Disability, the Executive shall be entitled to receive any amounts earned, accrued and owing but not yet paid under Section 2
above and any benefits accrued and due under any applicable benefit plans and programs of the Company. 
  

 5 

 9. Death. If the Executive dies while employed by the Company, the Executive’s
employment shall terminate on the date of death and the Company shall pay to the Executive’s executor, legal representative, administrator or designated beneficiary, as applicable, any amounts earned, accrued and owing but not yet paid under
Section 2 above and any benefits accrued and due under any applicable benefit plans and programs of the Company. Otherwise, the Company shall have no further liability or obligation under this Agreement to the Executive’s executors,
legal representatives, administrators, heirs or assigns or any other person claiming under or through the Executive. 
 10.
Cause. The Company may terminate the Executive’s employment at any time for Cause upon written notice to the Executive, in which event all payments under this Agreement shall cease, except for any amounts earned, accrued and owing but
not yet paid under Section 2 above and any benefits accrued and due under any applicable benefit plans and programs of the Company. 

11. Change of Control. 

(a) Acceleration of Equity Rights. Notwithstanding any provision to the contrary in any applicable plan, program or agreement, upon
the occurrence of a Change of Control (as defined in Section 12 below) during the Term, all outstanding stock options, restricted stock, restricted stock units and other equity rights held by the Executive as of the date of the Change of
Control will become fully vested and exercisable as of the date on which the Change of Control occurs. 
 (b) Application of
Section 280G of the Code. In the event a Change of Control occurs and the Executive becomes entitled to any benefits or payments in the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) under this Agreement,
or any other plan, arrangement, or agreement with the Company (the “Payments”), and such benefits or payments would (in the absence of this Section 11(b)) be subject to the tax (the “Excise Tax”) imposed by Section 4999
of the Code (or any similar tax that may hereafter be imposed), the aggregate present value of the Payments under this Agreement shall be reduced (but not below zero) to the Reduced Amount (as defined below), if reducing the Payments under this
Agreement will provide the Executive with a greater net after-tax amount than would be the case if no reduction was made. The “Reduced Amount” shall be an amount expressed in present value which maximizes the aggregate present value
of Payments without causing any Payment under this Agreement to be subject to the Excise Tax, determined in accordance with Section 280G(d)(4) of the Code. The Company shall reduce the Payments under this Agreement by first reducing
Payments that are payable in cash and then by reducing non-cash Payments. The fact that the Executive’s right to payments or benefits may be reduced by reason of the limitations contained in this Section 11(b), shall not of itself limit or
otherwise affect any other rights of the Executive other than pursuant to this Agreement. 
 (i)
Determinations; Timing of Payments. All determinations to be made under this Section 11(b) shall be made by the Company’s independent public accounting firm as in effect immediately prior to the Change of Control or another
qualified independent firm selected by the Company before the Change of Control (the “Accounting Firm”), which firm shall provide its determinations and any supporting calculations to the Company and Executive within 10 business days of
the event that gives rise to the “excess parachute payment.” Any such determination by the Accounting Firm shall be binding upon the Company and the Executive. Within five days after the Accounting Firm’s determination, the Company
shall pay (or cause to be paid) or distribute (or cause to be distributed) to or for the benefit of the Executive such amounts as are then due to the Executive under this Agreement. 

 

 6 

 (ii) Computation. For purposes of determining whether any of the
Payments will be subject to the Excise Tax, the amount of such Excise Tax, and the amount of any Reduced Amount, the Accounting Firm shall take into account any relevant guidance under the Code and the regulations thereunder, including, but not
limited to, the following: 
 (A) The amount of the Payments which shall be treated as subject to the Excise Tax
shall be equal to the amount of excess parachute payments within the meaning of Section 280G(b)(1) of the Code, as determined by the Accounting Firm; 

(B) The value of any non-cash benefits or any deferred or accumulated payment or benefit shall be determined by the
Accounting Firm in accordance with the principles of Sections 280G(d)(3) and (4) of the Code; and 
 (C) The
value of the non-competition covenants contained in this Agreement shall be taken into account to reduce “parachute payments” to the maximum extent allowable under Section 280G of the Code. The Company or the Accounting Firm may
retain a third-party valuation expert in order to determine the value of such covenants. The Accounting Firm shall be entitled to rely upon such expert valuation in making its determinations under this Section 11. 

For purposes of the determinations under this Section 11, the Executive shall be deemed to pay federal income taxes
at the highest marginal rate of federal income taxation in the calendar year in which the applicable payment is to be made, and state and local income taxes at the highest marginal rate of taxation in the state and locality of the Executive’s
residence, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. 

(iii) Overpayments and Underpayments. If as a result of a final IRS determination that any payments will have been
made by the Company which should not have been made (“Overpayment”), consistent with the calculations required to be made hereunder, any such Overpayment shall be treated for all purposes as a loan to the Executive which the Executive
shall repay to the Company, together with interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Code (the “Federal Rate”). If as a result of a final IRS determination that additional payments which have not
been made by the Company could have been made (“Underpayment”), consistent with the calculations required to be made hereunder, any such Underpayment shall be promptly paid by the Company to or for the benefit of the Executive, together
with interest at the Federal Rate. 
  

 7 

 (iv) Fees. All of the fees and expenses of the Accounting Firm in
performing the determinations referred to this Section 11(b) shall be borne solely by the Company. 
 (v)
Statutory Application. The limitations of this Section 11(b) shall only apply if payments under this Agreement are subject to Section 280G at the time of the Change of Control. 

12. Definitions. 

(a) Disability. For purposes of this Agreement, the term “Disability” shall mean the Executive is unable substantially to
perform the essential duties and responsibilities under this Agreement to the full extent required by the Board by reason of mental or physical illness, injury or any other cause for six consecutive months, or for more than nine months in the
aggregate during any period of 12 consecutive calendar months. 
 (b) Cause. For purposes of this Agreement,
“Cause” shall mean any of the following grounds for termination of the Executive’s employment: (i) the Executive is convicted of a felony, (ii) in the reasonable determination of the Board, the Executive has committed an
intentional act of fraud, embezzlement, or theft or engaged in gross negligence in connection with the Executive’s duties in the course of his/her employment with the Company, (iii) the Executive intentionally breached the Executive’s
obligations under this Agreement, including inattention to or neglect of duties and shall not have remedied such breach within 30 days after receiving written notice from the Board specifying the details thereof, provided, however, that in any case
under this clause (iii), the act or failure to act by the Executive is materially harmful to the business of the Company, and (iv) the failure by the Executive to follow the lawful directives of the Company’s Chief Executive Officer or its
Board, provided that (other than in the case of those actions or omissions set forth in clause (i) and (ii) above) the Executive shall have been given reasonably detailed notice that such an event constituting Cause for termination has
occurred and shall have been given at least 30 days opportunity to take remedial action but shall have failed or refused to do so. For purposes of this Agreement, an act or omission on the part of the Executive shall be deemed
“intentional” or “gross negligence” only if it was done by the Executive in bad faith, not merely an error in judgment, and without reasonable belief that the act or omission was in the best interest of the Company. 

(c) Good Reason. For purposes of this Agreement, the occurrence of one or more of the following actions after the occurrence of a
Change of Control shall constitute “Good Reason”: (i) a material diminution in the Executive’s duties, responsibilities or authority, (ii) a material reduction in the Executive’s Base Salary except as part of an across
the board reduction applicable to executives generally, or (iii) a failure of the Company to comply with any of the material terms of this Agreement, provided that the Company shall have been given reasonably detailed written notice that such
an event constituting cause for termination has occurred and shall have been given at least 30 days opportunity to take remedial action but shall have failed or refused to do so. The Executive must give the Company written notice within 90 days
following the event that constitutes Good Reason and the Executive’s termination must occur within one year following such event. 
  

 8 

 (d) Change of Control. For purposes of this Agreement, “Change of Control”
shall have the same meaning ascribed to such term under the Company’s 2007 Omnibus Equity Compensation Plan, as in effect on the date hereof and as it may be amended from time to time, or any successor plan. 

(e) Specified Executive. For purposes of this Agreement, “Specified Executive” shall mean an employee who, at any time
during the 12-month period ending on the identification date (defined below), is (i) an officer of the Company or a member of its controlled group (as determined for purposes of Section 416(i) of the Code) who has annual compensation
greater than $135,000 (or such other amount as may be in effect under Section 416(i)(1) of the Code), (ii) a 5% owner of the Company or (iii) a 1% owner of the Company who has annual compensation greater than $150,000. The
identification date shall be each December 31, and the determination of Specified Executives as of such identification date shall apply for the 12-month period following April 1 after the identification date. The determination of Specified
Executives, including the number and identity of persons considered officers, shall be made by the Company in accordance with the provisions of Sections 416(i) and 409A of the Code and the regulations issued thereunder. 

13. Restrictive Covenants. 

(a) Non-Competition. During the Term, and for the 12-month period beginning on the date the Executive’s employment terminates,
for any reason (the “Restriction Period”), the Executive hereby agrees that he/she will not, without the Company’s express written consent, engage (directly or indirectly) in any employment or business activity which designs,
manufactures, sells, licenses or markets any technologies or competing products of the Company or any of its subsidiaries or affiliates, or would otherwise conflict with the Executive’s employment by the Company. Such products and technologies
include those products and technologies which the Company or any of its subsidiaries or affiliates has developed, manufactured, sold, licensed or marketed now or, at the time of termination of Executive’s employment, may be in the process of
developing, manufacturing, selling, licensing or marketing. 
 (b) Non-Solicitation and Non-Hire of Company Personnel.
During the Term and for the Restriction Period, the Executive hereby agrees that he/she will not, either directly or through others, hire or attempt to hire, any current or former employee of the Company, or solicit or attempt to solicit any current
or former employee, consultant or independent contractor of the Company to change or terminate his, her or its relationship with the Company or otherwise to become an employee for or of any other person or business entity, unless more than 12 months
shall have elapsed between the last day of such person’s employment or service with the Company and the first date of such solicitation or hiring or attempt to solicit or hire. 

 

 9 

 (c) Non-Solicitation of Customers. During the Term and for the Restriction Period,
the Executive hereby agrees that he/she will not, either directly, through others or on behalf of third parties, solicit, divert or appropriate, or attempt to solicit, divert or appropriate any customer or actively sought prospective customer of the
Company for the purpose of providing such customer or actively sought prospective customer with services or products competitive with those offered by the Company during the Term. 

(d) Non-Disparagement. Executive agrees that Executive will not disparage the Company, its subsidiaries and parents, and their
respective officers, directors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and administrators, or make any public statement reflecting negatively on the Company, its subsidiaries and parents, and
their respective officers, directors, employees, and agents, and its and their respective successors and assigns, heirs, executors, and administrators, to third parties, including any matters relating to the operation or management of the Company,
irrespective of the truthfulness or falsity of such statement. 
 (e) Proprietary Information. At all times during
the Term and at all times thereafter, the Executive will hold in strictest confidence and will not disclose, use, lecture upon or publish any of the Company’s Proprietary Information (as defined below), except as such disclosure, use or
publication may be required in connection with the Executive’s work for the Company, or unless the Company expressly authorizes such disclosure in writing or disclosure is required by law or in a judicial or administrative proceeding, in which
event the Executive shall promptly notify the Company of the required disclosure and assist the Company if it determines to resist the disclosure. “Proprietary Information” shall mean any and all confidential and/or proprietary knowledge,
data or information of the Company, its affiliated entities and partners, including but not limited to information relating to financial matters, investments, budgets, business plans, marketing plans, personnel matters, business contacts, products,
processes, know-how, designs, methods, improvements, discoveries, inventions, ideas, data, programs, and other works of authorship. 

(f) Invention Assignment. The Executive agrees that all inventions, innovations, improvements, developments, methods, designs,
analyses, reports, and all similar or related information which relates to the Company’s actual or anticipated business, research and development or existing or future products or services and which are conceived, developed or made by Executive
while employed by the Company (“Work Product”) belong to the Company. The Executive will promptly disclose such Work Product to the Board and perform all actions reasonably requested by the Board (whether during or after the Term) to
establish and confirm such ownership (including, without limitation, assignments, consents, powers of attorneys and other instruments). 

(g) Return of Company Property. Upon termination of the Executive’s employment with the Company for any reason
whatsoever, voluntarily or involuntarily, and at any earlier time the Company requests, the Executive will deliver to the person designated by the Company all originals and copies of all documents and property of the Company in the Executive’s
possession, under the Executive’s control or to which the Executive may have access. The Executive will not reproduce or appropriate for the Executive’s own use, or for the use of others, any property, Proprietary Information or Company
inventions. 
  

 10 

 14. Legal and Equitable Remedies. Because the Executive’s services are personal
and unique and the Executive has had and will continue to have access to and has become and will continue to become acquainted with the proprietary information of the Company, and because any breach by the Executive of any of the restrictive
covenants contained in Section 13 would result in irreparable injury and damage for which money damages would not provide an adequate remedy, the Company shall have the right to enforce Section 13 and any of its provisions by injunction,
specific performance or other equitable relief, without bond and without prejudice to any other rights and remedies that the Company may have for a breach, or threatened breach, of the restrictive covenants set forth in Section 13. The
Executive agrees that in any action in which the Company seeks injunction, specific performance or other equitable relief, the Executive will not assert or contend that any of the provisions of Section 13 are unreasonable or otherwise
unenforceable. The Executive irrevocably and unconditionally (a) agrees that any legal proceeding arising out of this paragraph may be brought in the United States District Court for the Eastern District of Pennsylvania, or if such court does
not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction in Chester County, Pennsylvania, (b) consents to the non-exclusive jurisdiction of such court in any such proceeding, and (c) waives any objection
to the laying of venue of any such proceeding in any such court. The Executive also irrevocably and unconditionally consents to the service of any process, pleadings, notices or other papers. 

15. Arbitration; Expenses. In the event of any dispute under the provisions of this Agreement, other than a dispute in which the
primary relief sought is an equitable remedy such as an injunction, the parties shall be required to have the dispute, controversy or claim settled by arbitration in Philadelphia, Pennsylvania in accordance with the National Rules for the Resolution
of Employment Disputes then in effect of the American Arbitration Association, before an arbitrator agreed to by both parties. If the parties cannot agree upon the choice of arbitrator, the Company and Executive will each choose an arbitrator. The
two arbitrators will then select a third arbitrator who will serve as the actual arbitrator for the dispute, controversy or claim. Any award entered by the arbitrators shall be final, binding and nonappealable and judgment may be entered thereon by
either party in accordance with applicable law in any court of competent jurisdiction. This arbitration provision shall be specifically enforceable. The arbitrators shall have no authority to modify any provision of this Agreement or to award a
remedy for a dispute involving this Agreement other than a benefit specifically provided under or by virtue of the Agreement. Each party shall be responsible for its own expenses, unless the Executive shall prevail in an arbitration proceeding as to
any material issue, in which case the Company shall reimburse the Executive for all reasonable costs, expenses and fees relating to the conduct of the arbitration (including reasonable attorneys’ fees and expenses) and shall share the fees of
the American Arbitration Association. 
 16. Survival. The respective rights and obligations of the parties hereunder
shall survive the termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations. 

17. Mitigation. The Company’s obligations to make payments under this Agreement and otherwise to perform its obligations
hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which the Company may have against Executive or others. 

 

 11 

 18. Notices. All notices and other communications required or permitted under this
Agreement or necessary or convenient in connection herewith shall be in writing and shall be deemed to have been given when hand delivered or mailed by registered or certified mail, as follows (provided that notice of change of address shall be
deemed given only when received): 
 If to the Company, to: 

Orthovita, Inc. 

77 Great Valley Parkway 

Malvern, PA 19355 

Attention: Vice President, Human Resources 

If to the Executive, to the most recent address on file with the Company or to such other names or addresses as the Company or the
Executive, as the case may be, shall designate by notice to each other person entitled to receive notices in the manner specified in this Section or as provided on the Company’s website, www.orthovita.com. 

19. Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the Company shall
withhold from any payments under this Agreement all federal, state and local taxes that the Company is required to withhold pursuant to any law or governmental rule or regulation. The Executive shall bear all expense of, and be solely responsible
for, all federal, state and local taxes due with respect to any payment received under this Agreement. 
 20. Remedies
Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be exclusive of any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given under this Agreement
or now or hereafter existing at law or in equity. No delay or omission by a party in exercising any right, remedy or power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or
power may be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in its sole discretion. 

21. Assignment. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be
enforceable by the respective heirs, executors, administrators, legal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities of the Executive under this Agreement are of a personal nature and shall
not be assignable or delegable in whole or in part by the Executive. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation, reorganization or otherwise) to all or substantially all of the business or
assets of the Company, within 15 days of such succession, expressly to assume and agree to perform this Agreement in the same manner and to the same extent as the Company would be required to perform if no such succession had taken place and the
Executive acknowledges that in such event the obligations of the Executive hereunder, including but not limited to those under Sections 13 and 14, will continue to apply in favor of the successor. 

 

 12 

 22. Entire Agreement. This Agreement sets forth the entire agreement of the parties
hereto and supersedes any and all prior agreements and understandings concerning the Executive’s employment by the Company. This Agreement may be changed only by a written document signed by the Executive and the Company. 

23. Section 409A of the Code. 

(a) This Agreement is intended to comply with Section 409A of the Code and its corresponding regulations, or an exemption, and
payments may only be made under this Agreement upon an event and in a manner permitted by Section 409A, to the extent applicable. Severance benefits under the Agreement are intended to be exempt from Section 409A under the “separation
pay exception,” to the maximum extent applicable, or another exemption. Notwithstanding anything in this Agreement to the contrary, if required by Section 409A, if the Executive is considered a “specified employee” for purposes
of Section 409A and if payment of any amounts under this Agreement is required to be delayed for a period of six months after separation from service pursuant to Section 409A, payment of such amounts shall be delayed as required by
Section 409A, and the accumulated amounts shall be paid in a lump sum payment within ten days after the end of the six-month period. If the Executive dies during the postponement period prior to the payment of benefits, the amounts withheld on
account of Section 409A shall be paid to the personal representative of the Executive’s estate within 60 days after the date of the Executive’s death. 

(b) All payments to be made upon a termination of employment under this Agreement may only be made upon a “separation from
service” under Section 409A. For purposes of Section 409A of the Code, the right to a series of payments under this Agreement shall be treated as a right to a series of separate payments. In no event may the Executive, directly or
indirectly, designate the calendar year of a payment. All reimbursements and in-kind benefits provided under the Agreement shall be made or provided in accordance with the requirements of Section 409A. 

24. Severability. If any provision of this Agreement or application thereof to anyone or under any circumstances is adjudicated to
be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other provision or application of this Agreement which can be given effect without the invalid or unenforceable provision or application and
shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is held void, invalid or unenforceable with respect to particular circumstances, it shall nevertheless remain in full force and
effect in all other circumstances. 
 25. Governing Law. This Agreement shall be governed by, and construed and enforced
in accordance with, the substantive and procedural laws of the Commonwealth of Pennsylvania without regard to rules governing conflicts of law. 

26. Counterparts. This Agreement may be executed in any number of counterparts (including facsimile counterparts), each of which
shall be an original, but all of which together shall constitute one instrument. 
  

 13 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on August 4, 2010.

  

			
	ORTHOVITA, INC.
		
	By:	 	 /s/ Antony Koblish

		 	President and Chief Executive Officer
	
	EXECUTIVE
	
	 /s/ Maarten Persenaire

	Maarten Persenaire, M.D.

  

 14Separation Agreement

 Exhibit 10.1 

 

 

 May 24, 2010 

Mr. Ronald V. Waters III 
 Dear Ron:

 This letter agreement (the “Agreement”) will confirm that we have agreed to the following terms and conditions
regarding your resignation from your position of Chairman, President and Chief Executive Officer of LoJack Corporation (“LoJack” or the “Company”). 

1. Employment Status. 

(a) You have resigned from your current office as the Company’s Chairman, President and Chief Executive Officer effective as of
May 24, 2010 (“Resignation Date”). On the Resignation Date you shall also resign from your current position as an officer of any LoJack subsidiary. 

(b) For the period beginning on the Resignation Date and continuing until December 31, 2010 (the “Post CEO Period”), you
shall assist in transitioning your responsibilities and be available to consult with the Company on matters consistent with your LoJack experience and your other activities as LoJack reasonably may request. 

(c) All payments hereunder shall commence on Final Acceptance of this Agreement (as defined in Paragraph 11). During the Post CEO Period,
the Company shall pay you an amount equal to your current salary level per bi-weekly pay period, less withholdings as required by law or as authorized by you, which will be paid in bi-weekly installments. On the Resignation Date, LoJack shall pay
you all accrued but unused vacation pay. 
 (d) During the Post CEO Period, the Company will continue to pay the portion of your
prior employer’s group medical and dental plan benefits to the same extent that the Company paid immediately preceding your Resignation Date. The Company will reimburse you up to $10,000 for outplacement services incurred by you during the Post
CEO Period. You will not be entitled to other LoJack benefits, except as prescribed by law or as described below. You are not entitled to COBRA benefits as you were not a participant in LoJack plans during the term of your employment with the
Company. Your Change in Control Agreement with the Company, dated February 26, 2007, shall terminate as of the Resignation Date and, pursuant to the terms of the Change in Control Agreement, be of no further force and effect as of ninety
(90) days after the Resignation Date. 
 (e) You may, at your option, purchase from the Company your cell phone and laptop
computer at their current book value to the Company. The Company will assist with the transfer of your cell phone number to your personal account. 

2. 2010 Bonus: You shall be entitled to receive the prorated portion (for the period of time actually worked prior to your
Resignation Date) of your annual bonus for 2010, to be paid not later than March 15, 2011, if at all, in accordance with the terms of the Company’s Annual Incentive Plan and consistent with the annual bonuses paid to the Company’s
executive officers at such time under the Annual Incentive Plan. 
 3. Transition Expenses: Within thirty (30) days
of the Resignation Date, the Company shall pay you $30,000, less withholdings to the extent required by law, to assist with transition expenses, including moving expenses, lease costs, and taxes. On September 30, 2010, the Company shall
reimburse you up to an additional $15,000, less withholdings to the extent required by law, of expenses incurred by you during the Post CEO period, to the extent such expenses exceed the initial $30,000 referenced in this Section 3. 

 4. Equity Awards: Except as otherwise provided in this Section 4, your
outstanding equity grants shall be governed by the terms of the Company’s 2008 Stock Incentive Plan and the respective grant documents, including the stock option agreements and restricted stock agreements, as the case may be. 

(a) Your 2010 performance share grant shall vest or be forfeited in a manner, and at such time, consistent with the Compensation’s
Committee treatment of such performance shares for all other executive officers in 2011. 
 (b) Your May 2008 and December 2008
time based restricted stock grants shall vest in full on December 31, 2010. Your March 2010 time based restricted stock grant shall be forfeited in its entirety on the Resignation Date. 

(c) The unvested portion of your 2007 and 2008 stock option grants, and the entire March 2010 stock option grant, shall be forfeited in
their entirety on the Resignation Date. During the post CEO Period, you shall be entitled to continue to vest your December 2008 stock options grant as though you remained an employee of the Company during such period. On December 31, 2010, an
additional 35,080 of the 70,159 then unvested stock options shall vest and you will forfeit the remaining 35,079 unvested stock options from the December 2008 grant. You shall be entitled to exercise all vested stock options through until their
natural expiration date. 
 5. Termination of Payments. In addition to other remedies, all payments and benefits will be
terminated in the event of (i) your engaging in conduct which is demonstrably and materially injurious to the Company or that materially harms the reputation or financial position of the Company; (ii) your conviction of, or plea of guilty
or nolo contendere to, a felony or any other crime involving dishonesty, fraud or moral turpitude; (iii) your being found liable in any SEC or other civil or criminal securities law action relating to the Company, or the entry of any
cease and desist order with respect to such action (regardless of whether or not you admit or deny liability); (iv) your breach of your fiduciary duties to the Company which may reasonably be expected to have a material adverse effect on the
Company; (v) your obstructing or impeding, or failing to materially cooperate with, any investigation authorized by the Board or any governmental or self-regulatory entity involving the Company; (vi) your violation of any nondisclosure,
nonsolicitation, non-hire, or noncompete agreement and/or the provisions of Sections 8 and 9 below; or (vii) your violation of the Company’s Code of Ethics, Corporate Governance Guidelines and any Company policies concerning insider
trading, that you know or reasonably should know could reasonably be expected to result in a material adverse effect on the Company or its reputation. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by
the Board or based upon the advice of counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by you in good faith and in the best interests of the Company. 

You may elect to convert your Basic Life Insurance coverage to an individual policy with Reliance Standard Insurance Company. You also
have the option to port any voluntary life insurance you have through LoJack. If you are interested in exploring either one or both of these options, please contact the Benefits Department at LoJack for the appropriate forms as soon as possible.
Please note that you only have 31 days to submit these forms to Reliance Standard Insurance Company in order to convert/port your current coverage to individual policies. 

6. Indemnification. The Company shall continue to provide you with indemnification as provided in the Company’s By-Laws and
Articles of Organization. 

 7. Releases. 

(a) First General Release of Claims. In exchange for the promises set forth herein, you, on behalf of yourself and your heirs,
executors, administrators and assigns, hereby release and forever discharge LoJack Corporation, its affiliates and each of their respective directors, officers, employees, agents, successors and assigns, in their individual and official capacities,
from any and all suits, claims, demands, debts, sums of money, damages, interest, attorneys’ fees, expenses, actions, causes of action, judgments, accounts, promises, contracts, agreements, and any and all claims of law or in equity, whether
now known or unknown, which you now have or ever have had against them, or any of them, including, but not limited to, any claims under Title VII of the Civil Rights Act of 1964, the Americans With Disabilities Act, the Age Discrimination in
Employment Act, the Older Workers Benefit Protection Act, Massachusetts General Laws Chapters 149 and 151B and any other federal, state or local statute, regulation, ordinance or common law creating employment-related causes of action, and all
claims related to or arising out of your employment or the termination of your employment with LoJack. You also hereby waive any claim for reinstatement, attorney’s fees, or costs. Nothing in this General Release shall prevent you from seeking
to enforce your rights under this Agreement or any vested right which you have under any plans and grants referred to herein or any Company employee retirement or welfare benefit plan. You hereby represent that you have not previously filed or
joined in any complaints, charges or lawsuits against LoJack pending before any governmental agency or court of law relating to your employment and/or the cessation thereof. 

(b) Second General Release of Claims. Your eligibility to receive the payments and benefits described in Section 2 and
Section 4(a) after the Post CEO Period is conditional upon your signing and delivering a second General Release of Claims containing substantially the same provisions of Section 7(a) with such changes as may be necessary or deemed
desirable by LoJack because of changes in applicable law, releasing LoJack Corporation, its affiliates and each of their directors, officers, employees, agents, successors and assigns, in their individual and official capacities, from any and all
claims that may have arisen between the date you sign this Agreement and the conclusion of the Post CEO Period. Nothing in this General Release shall prevent you from seeking to enforce your rights under this Agreement or any vested right which you
have under any plans and grants referred to herein or any Company employee retirement or welfare benefit plan. 
 8.
Reaffirmation of Confidentiality Obligation; Return of LoJack Property. You hereby acknowledge and reaffirm your continuing obligation of confidentiality regarding LoJack’s Confidential and Proprietary Information as set forth in the
LoJack Corporation Employee Obligations and Responsibilities. After your employment at LoJack, you will not at any time, without LoJack’s prior written consent, reveal or disclose to any person outside of LoJack, or use for your own benefit or
for the benefit of any other person or entity, any confidential information concerning LoJack’s business, customers, clients, or employees. Confidential information includes, without limitation, financial information, reports, forecasts,
intellectual property, trade secrets, know-how, software, market or sales information and plans, client lists, business plans, prospects and opportunities. All documents, records, materials, software, equipment, office entry cards or keys and other
physical property, and all copies of the same that have come into your possession or been produced by you in connection with your employment, have been and remain the sole property of LoJack. Except as otherwise provided in Section 1(e), you
agree that you shall return all such property to LoJack within ten (10) days of your Resignation Date. 
 9.
Non-solicitation; Non-hire; Covenant Against Competition. You agree that for a period of one (1) year after the conclusion of the Post CEO Period (the “Restricted Period”) you will not, directly or indirectly, on your own
behalf or on behalf of any third person or entity, and whether through your own efforts or through the efforts or employing the assistance of any other person or entity (including without limitation any consultant or any person employed by or
associated with any entity with whom you are employed or associated): 
 (a) knowingly hire or employ any employee of LoJack, or
solicit or induce any such employee to terminate his/her employment or other relationship with LoJack. 

 (b) solicit or accept business, compensation, employment or other position from or own any
interest in (i) any former or present partners, affiliates or foreign licensees of LoJack or with Absolute Software Inc. or SC Integrity Inc.; or (ii) any person or entity engaged in any aspect of the business of stolen vehicle tracking
and recovery, the tracking, location or recovery of valuable mobile assets including safety and security vehicle telematics applications; provided, however, that this section 9(b) shall not limit or restrict you or your employer from providing
professional accounting, consulting or advisory services to LoJack, its officers or its licensees. You acknowledge that (i) the principal business of the Company (which expressly includes for purposes of this Section 9 and any related
enforcement provisions hereof, its successors and assigns) is the offering of products and services relating to stolen vehicle tracking and recovery, the tracking, location or recovery of valuable mobile assets including safety and security vehicle
telematics applications; (ii) LoJack is one of the limited number of persons who have developed such a business; (iii) LoJack’s business is national and international in scope; (iv) your work for LoJack has given you access to
the confidential affairs and proprietary information of the Company; (v) your covenants and agreements contained in Section 8 and this Section 9 are essential to the business and goodwill of LoJack; and (vi) LoJack would not have
entered into this Agreement but for the covenants and agreements set forth in Section 8 and this Section 9. Accordingly, you covenant, agree and acknowledge that (i) you have had an opportunity to seek advice of counsel in connection
with this Agreement and (ii) the restrictive covenants are reasonable in geographical and temporal scope and in all other respects. It is the express intent of the parties that (a) in case any one or more of the provisions contained in
this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity, or subject, such provision shall be construed by limiting and reducing it as determined by a court of competent jurisdiction, so as to
be enforceable to the fullest extent compatible with applicable law; and (b) in case any one or more of the provisions contained in this Agreement cannot be so limited and reduced and for any reason is held to be invalid, illegal, or
unenforceable, such invalidity, illegality, or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal, or unenforceable provision had never been contained herein.

 10. Mutual Non-Disparagement. You agree not to take any action or make any statement, written or oral, that disparages
LoJack or any of LoJack’s directors, officers, employees or agents, or that has the intended or foreseeable effect of harming LoJack’s reputation or the personal or business reputation of any of LoJack’s directors, officers, employees
or agents. Similarly, LoJack agrees that its directors and officers will not take any action or make any statement, written or oral, that disparages you or that has the intended or foreseeable effect of harming your reputation or your personal or
business reputation and will not authorize any other employee to make any statement in behalf of the Company. 
 11.
Consultation with Counsel; Time for Signing; Revocation. You acknowledge that LoJack has advised you of your right to consult with an attorney of your own choice prior to signing this Agreement. You have until twenty-one (21) days from
your receipt of this Agreement to decide whether to sign it. You will have seven (7) days after signing this Agreement to revoke your signature. If you intend to revoke your signature, you must do so in a writing addressed and delivered to me
prior to the end of the 7-day revocation period. This Agreement shall not be effective, and neither LoJack nor you shall have any rights or obligations hereunder, until the expiration of the 7-day revocation period (“Final Acceptance”).

 12. Section 409A. In order to comply with Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”), if you are determined to be a “specified employee” as defined in Section 409A of the Code at the time any payment of nonqualified deferred compensation is made, and the deferral of the commencement of any payments
or benefits otherwise payable hereunder as a result of your resignation is necessary in order to prevent the imposition of any accelerated or additional tax under Section 409A of 

 
the Code, the Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid or provided to you)
until the date that is six months following your Resignation Date with the Company and its affiliates (or the earliest date as is permitted under Section 409A of the Code). 

Further, it is the intention of the parties that no payment or entitlement pursuant to this Agreement will give rise to any adverse tax
consequences to any person pursuant to Section 409A of the Code. Notwithstanding any provision in this Agreement to the contrary, this Agreement shall be interpreted, applied and to the minimum extent necessary, amended, so that this Agreement
does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. Any reference in this Agreement to Section 409A of the Code shall also include any proposed, temporary or final regulations, or any
other guidance, promulgated with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service. 

13. General Provisions. 

(a) Severability. The invalidity or unenforceability of any provision of this Agreement shall in no way affect the validity or
enforceability of any other provisions, or any part, hereof. 
 (b) Enforcement; Applicable Law; Jurisdiction. This
Agreement is intended to operate as a contract under seal and shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts. You agree that all disputes arising under or out of this Agreement shall be brought in
courts of competent jurisdiction within the Commonwealth of Massachusetts and you hereby consent to exclusive jurisdiction in courts located in the Commonwealth of Massachusetts with respect to all matters arising out of or related to this
Agreement. 
 (c) Entire Agreement. This Agreement constitutes the entire agreement between you and LoJack concerning the
terms and conditions of your separation from employment with LoJack and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written, between you and LoJack, except for (i) the
LoJack Corporation Employee Obligations and Responsibilities, referenced in Section 8, and (ii) your stock option agreement and restricted stock agreements with the Company, which shall remain in full force and effect except as expressly
modified herein. You agree that LoJack has not made any warranties, representations, or promises to you regarding the meaning or implication of any provision of this Agreement other than as stated herein. 

(d) Modification and Waiver. This Agreement may be amended or modified only by a written instrument signed by you and an
authorized representative of LoJack. The failure of you or LoJack at any time to require the performance of any provision of this Agreement shall in no manner affect the right of such party at a later time to enforce the same provision. 

(e) Successors and Assigns. All of the terms, conditions and obligations hereof shall be for and inure to the benefit of and shall
be enforceable by the successors and assigns of LoJack Corporation. You hereby assent to the assignment of this Agreement by LoJack to any successor to or assignee of its business. 

 Please indicate your understanding and acceptance of this Agreement by signing and returning
one copy to me. The other copy is for your records. 
  

					
	Sincerely,	 		 	
			
	 /s/ Timothy P. O’Connor
	 		 	
	 Timothy P. O’Connor

Senior Vice President and Chief Financial Officer
	 		 	
			
	LoJack Corporation	 		 	
			
	Accepted and Agreed	 		 	
			
	 /s/ Ronald V. Waters III
	 		 	Dated: May 24, 2010
	Ronald V. Waters III

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]